Screener
NewAmsterdam Pharma Company NAMS Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by NewAmsterdam Pharma Company in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: NewAmsterdam Pharma Company’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333824
| Line item | For the three months ended June 30, 2026 | For the three months ended June 30, 2025 | For the six months ended June 30, 2026 | For the six months ended June 30, 2025 |
|---|---|---|---|---|
| Research and development expenses | 41,673 | 27,516 | 79,682 | 72,267 |
| Selling, general and administrative expenses | 26,892 | 27,264 | 50,343 | 54,416 |
| Total operating expenses | 68,565 | 54,780 | 130,025 | 126,683 |
| Operating loss | (64,864) | (35,635) | (123,284) | (104,560) |
| Other income (expense): | ||||
| Interest income | 5,810 | 7,055 | 11,460 | 14,406 |
| Fair value change – earnout | — | — | — | 3,992 |
| Fair value change – warrants | (4,555) | 2,590 | 1,387 | 16,352 |
Item 1. Financial Statements.
FAQ
- What is NewAmsterdam Pharma Company's operating income?
- NewAmsterdam Pharma Company (NAMS) reported operating income of -$64.86M in Q2 2026.
- How has NewAmsterdam Pharma Company's operating income changed year-over-year?
- NewAmsterdam Pharma Company's operating income decreased by 82.0% year-over-year, from -$35.64M to -$64.86M.
- What is the long-term trend for NewAmsterdam Pharma Company's operating income?
- Over 4 years (2021 to 2025), NewAmsterdam Pharma Company's operating income has grown at a 59.4% compound annual growth rate (CAGR), from -$34.98M to -$225.68M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about NewAmsterdam Pharma Company's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude